Complex Regional Pain Syndrome clinical trials at UCSD
2 research studies open to eligible people
Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regional Pain Syndrome
open to eligible people ages 21-75
The aim of this trial is to determine the potential effects and mechanisms of cannabinoid-induced pain relief in complex regional pain syndrome (CRPS). Multiple psychophysical approaches will be conducted in conjunction with psychological and inflammatory marker testing to determine if and how cannabinoids produce stabilized improvement in CRPS-related pain and comorbidities. The trial consisted of a pre-treatment screening period, six-week treatment period and a two-week follow-up.
La Jolla, California and other locations
IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
open to eligible people ages 18 years and up
Phase 3 Trial of AMBTX-01 (neridronate) for Complex Regional Pain Syndrome Type 1
La Jolla, California and other locations
Our lead scientists for Complex Regional Pain Syndrome research studies include Fadel Zeidan, PhD.
Last updated: